Research advances of treatment for desmoid tumor

Shu LI,Zhi-wei FANG

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2010.17.021

2010-01-01

Abstract:OBJECTIVE: To summarize the advance of research on comprehensive treatment of desmoid tumor, and discuss its clinical therapy strategy. METHODS: Articles were retrieved in PubMed and CNKI with "desmoid tumor", "aggressive fibromatosis" and "desmoid type fibromatosis" as keywords. Inclusion criteria: 1) surgical treatment and follow-up of desmoid tumor. 2) radiotherapeutic treatment and follow-up of desmoid tumor. 3) pharmacologic treatment and follow-up of desmoid tumor. 4) advances in therapy strategy and fundamental research of desmoid tumor. Exclusion criteria: repeated similar researches. According to the inclusion criteria, finally 34 articles were reviewed. RESULTS: It is generally believed that the surgery should be the first-line therapy, and the negative margin should be a-chieved with acceptable function. The main adjuvant treatment is radiotherapy. The patients with positive margins or unresectable tumor should receive radiotherapy. The pharmacologic treatment is considered as a third-line treatment for patients who are not suitable for surgery and radiotherapy. CONCLUSIONS: The low morbidity makes the prospective randomized controlled study absent in the literature, and there is no consensus on the optimal treatment strategy until now. Individual treatment should be made for every patient under the guidance of the " surgical-radiotherapeutic-pharmacologic treatment" strategy.